The role of 17 α-hydroxyprogesterone caproate in the prevention of preterm birth

ISSN： 1745-5057

Source： Women's Health, Vol.2, Iss.6, 2006-11, pp. : 819-824

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

17-α hydroxyprogesterone caproate for the prevention of preterm birth

By Gupta Simi Roman Ashley S

Women's Health, Vol. 8, Iss. 1, 2012-01 ,pp. : 21-30

Future Medicine

Access to resources Recommend Favorite

Is 17α‐hydroxyprogesterone caproate contraindicated in twin gestations?

BJOG : AN INTERNATIONAL JOURNAL OF OBSTETRICS & GYNAECOLOGY, Vol. 122, Iss. 1, 2015-01 ,pp. : 6-7

John Wiley & Sons Inc

Access to resources Recommend Favorite

Population pharmacokinetics of 17α‐hydroxyprogesterone caproate in singleton gestation

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (ELECTRONIC), Vol. 82, Iss. 4, 2016-10 ,pp. : 1084-1093

John Wiley & Sons Inc

Access to resources Recommend Favorite

A randomised controlled double‐blind clinical trial of 17‐hydroxyprogesterone caproate for the prevention of preterm birth in twin gestation (PROGESTWIN): evidence for reduced neonatal morbidity

BJOG : AN INTERNATIONAL JOURNAL OF OBSTETRICS & GYNAECOLOGY, Vol. 122, Iss. 1, 2015-01 ,pp. : 71-79

John Wiley & Sons Inc

Access to resources Recommend Favorite

Pharmacogenomics of 17‐alpha hydroxyprogesterone caproate for recurrent preterm birth: a case–control study

BJOG : AN INTERNATIONAL JOURNAL OF OBSTETRICS & GYNAECOLOGY, Vol. 125, Iss. 3, 2018-02 ,pp. : 343-350

John Wiley & Sons Inc

Access to resources Recommend Favorite